tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Nippon Shinyaku’s Promising Phase 2 Trial for Autoimmune Treatment
PremiumCompany AnnouncementsNippon Shinyaku’s Promising Phase 2 Trial for Autoimmune Treatment
4M ago
Nippon Shinyaku Completes Treasury Stock Disposal for Executive Compensation
Premium
Company Announcements
Nippon Shinyaku Completes Treasury Stock Disposal for Executive Compensation
6M ago
Nippon Shinyaku Reports Q1 2025 Financial Results with Mixed Performance
Premium
Company Announcements
Nippon Shinyaku Reports Q1 2025 Financial Results with Mixed Performance
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100